Arbutus Biopharma Corp (ABUS) — Net Asset Quality Index
Arbutus Biopharma Corp (ABUS) has a Net Asset Quality Index of 80.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $94.62 Million minus total liabilities of $18.04 Million yields net assets of $76.58 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Arbutus Biopharma Corp liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Arbutus Biopharma Corp Net Asset Quality Index Over Time (1998–2025)
This chart shows how Arbutus Biopharma Corp's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of December 2025, the index stands at 80.9%, representing net assets of $76.58 Million against total assets of $94.62 Million USD. See Arbutus Biopharma Corp (ABUS) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Arbutus Biopharma Corp (1998–2025)
The table below presents the year-by-year Net Asset Quality Index for Arbutus Biopharma Corp from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Arbutus Biopharma Corp (ABUS) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.9% | $76.58 Million | $94.62 Million | $18.04 Million | ▲ +7.0 pp |
| 2024 | 73.9% | $97.37 Million | $131.71 Million | $34.34 Million | ▲ +0.5 pp |
| 2023 | 73.4% | $106.02 Million | $144.40 Million | $38.38 Million | ▲ +3.4 pp |
| 2022 | 70.0% | $136.85 Million | $195.42 Million | $58.57 Million | ▼ -12.8 pp |
| 2021 | 82.9% | $169.44 Million | $204.49 Million | $35.05 Million | ▲ +8.5 pp |
| 2020 | 74.4% | $101.97 Million | $137.08 Million | $35.11 Million | ▲ +5.5 pp |
| 2019 | 68.9% | $72.74 Million | $105.53 Million | $32.79 Million | ▼ -18.9 pp |
| 2018 | 87.9% | $200.23 Million | $227.91 Million | $27.67 Million | ▲ +10.9 pp |
| 2017 | 76.9% | $182.50 Million | $237.20 Million | $54.70 Million | ▲ +3.4 pp |
| 2016 | 73.6% | $203.00 Million | $275.90 Million | $72.90 Million | ▼ -3.3 pp |
| 2015 | 76.9% | $547.68 Million | $712.29 Million | $164.61 Million | ▲ +2.4 pp |
| 2014 | 74.5% | $88.00 Million | $118.20 Million | $30.20 Million | ▼ -8.1 pp |
| 2013 | 82.5% | $59.19 Million | $71.72 Million | $12.52 Million | ▲ +4.7 pp |
| 2012 | 77.8% | $40.92 Million | $52.60 Million | $11.68 Million | ▲ +39.8 pp |
| 2011 | 38.0% | $5.21 Million | $13.70 Million | $8.50 Million | ▼ -13.1 pp |
| 2010 | 51.1% | $10.73 Million | $21.02 Million | $10.29 Million | ▼ -33.4 pp |
| 2009 | 84.5% | $35.44 Million | $41.95 Million | $6.51 Million | ▼ -5.9 pp |
| 2008 | 90.4% | $38.29 Million | $42.34 Million | $4.05 Million | ▲ +16.5 pp |
| 2007 | 74.0% | $18.37 Million | $24.83 Million | $6.46 Million | ▲ +71.4 pp |
| 2006 | 2.6% | $155.53K | $6.03 Million | $5.88 Million | ▲ +102.6 pp |
| 2005 | -100.0% | $-18.49 Million | $18.50 Million | $36.99 Million | ▼ -74.5 pp |
| 2004 | -25.5% | $-10.50 Million | $41.10 Million | $51.60 Million | ▼ -111.1 pp |
| 2003 | 85.5% | $43.38 Million | $50.73 Million | $7.35 Million | ▲ +0.3 pp |
| 2002 | 85.2% | $45.35 Million | $53.22 Million | $7.87 Million | ▼ -5.7 pp |
| 2001 | 91.0% | $61.49 Million | $67.60 Million | $6.12 Million | ▼ -1.4 pp |
| 2000 | 92.3% | $30.03 Million | $32.52 Million | $2.49 Million | ▼ -1.0 pp |
| 1999 | 93.3% | $26.88 Million | $28.80 Million | $1.92 Million | ▲ +2.2 pp |
| 1998 | 91.1% | $14.43 Million | $15.83 Million | $1.40 Million | — |